David Routman
@davidroutmanmd
Assistant Professor | Radiation Oncology | Mayo Clinic. Views are my own and subject to change
ID: 1119043205612363777
19-04-2019 01:01:05
112 Tweet
388 Followers
591 Following
Circulating tumor DNA (ctDNA) is a cost-effective and accurate post-treatment surveillance strategy for HPV-associated oropharyngeal cancer, compared with imaging-based strategies. Mayo Clinic Radiation Oncology Roman Kowalchuk David Routman ja.ma/32u0Ijg
This #WeWhoCurie Wednesday, we feature Nadia Laack, MD MS! Dr. Laack highlights the privilege of working with our patients and their families, the challenge of developing new technologies, and the goal of achieving balance in our lives. #RadOnc
Terrific work Daniel Ma David Routman Bhisham Chera, MD !! Could next step may be randomizing postop ctHPVDNA(-) patients to observation or PORT? redjournal.org/article/S0360-…
Thank you to the fantastic Mayo Clinic #RadOnc residents who bring their all every day for our patients. #thankaresidentday Elizabeth Belle Jeans, MEd, MD Danielle A. Cunningham, MD Lindsay Morris, MD Roman Kowalchuk Kimberly Gergelis, MD Robert Gao, MD William Breen Kaitlin Qualls, MD Dan Ebner
Erin Gillespie, MD MPH presents a provocative phase II RCT of prophylactic #radiotherapy to asymptomatic but high risk bone Mets. N=93 Convincing home run, 29% vs 1.6% skeletal related events, with an ⬆️ OS benefit! Remained significant on MVA #ASTRO22 #OncoAlert
Fantastic presentation by William Breen of Mayo Clinic Comprehensive Cancer Center / Mayo Clinic Radiation Oncology on behalf of Alliance for Clinical Trials in Oncology demonstrating the critical role central review in the results of N107C/CEC.3.
What a packed day! Started off with our team winning 🥇Radiation Oncology Institute-The ASTRO Foundation 5k with Hunter Gits winning 🥈, great talks by residents Jessica Burlile, Robert Gao, MD & prospective med student Ben Talom, and a round of 👏🏼 to William Breen for his late-breaking CNS work. #ASTRO22
I love this: The V Foundation for Cancer Research grantee Dr. @BackumGamez describes a potential method for detecting endometrial cancer using vaginal fluid collected from tampons. Big step from current methods which are uncomfortable, invasive, and unavailable to many women.gynecologiconcology-online.net/article/S0090-…
Happy to share our newest publication on patterns and distribution of lymph node metastases and nodal recurrence in surgically treated oropharynx cancer patients. Thank you for excellent supervision Katie Van Abel (she/her(s)) David Routman Read it here: authors.elsevier.com/c/1hnUL4tFDIK5…
As is tradition, the Mayo Clinic Comprehensive Cancer Center Head and Neck Disease Group held its annual retreat right before #HNCS24. A great time to refine practice recs, develop new research, and start multi-d care initiatives!
Congratulations to all participating institutions for driving Phase III Level I evidence for proton therapy in head and neck malignancies to be presented ASCO on June 4th. meetings.asco.org/abstracts-pres… MD Anderson Cancer Center National Association for Proton Therapy ASTRO
I'm extremely excited to be joining this team next year -- hope you'll join us! jobs.mayoclinic.org/job/rochester/… Daniel Ma David Routman @TheColonelGray Jessica Wilson Timothy Malouff Nadia Laack, MD MS Mayo Clinic Radiation Oncology
Reclassifying each N category 1 stratum higher for imaging-detected extranodal extension-positive disease resulted in better disease-free and overall survival in patients human papillomavirus–positive oropharyngeal carcinoma. ja.ma/4k0TANm Melvin LK CHUA | FRCR, PhD, FASCO
.David Routman presented an investigator-initiated study on the use of a therapeutic vaccine alone or combined with pembrolizumab in #HPV-associated oropharyngeal carcinoma. This novel therapy is directed at HPV E6 & E7 and was delivered prior to surgery or radiation. #ASCO25
